Manipal Health Enterprises (BOM:544847) 5-Year Yield-on-Cost %: 0.00 (As of Aug. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544847 Manipal Health Enterprises Ltd BOM:544847
13 GF Score
Price ₹771.85
! 1 Warning Sign
View Full Analysis

What is Manipal Health Enterprises 5-Year Yield-on-Cost %?

Manipal Health Enterprises BOM:544847 -3.22% 13 5-Year Yield-on-Cost % is 0.00 as of Aug. 31, 2026. GuruFocus rates BOM:544847 with a GF Score™ of 13/100. The stock has 1 warning sign investors should review. Among 280 Healthcare Providers & Services companies, Manipal Health Enterprises ranks worse than 357142.5% on this metric.

Manipal Health Enterprises's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for Manipal Health Enterprises's 5-Year Yield-on-Cost % or its related term are showing as below:



BOM:544847's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.945
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Manipal Health Enterprises  (BOM:544847) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Manipal Health Enterprises 5-Year Yield-on-Cost % Related Terms


BOM:544847 vs HCA, THC, EHC: 5-Year Yield-on-Cost % Comparison

For the Medical Care Facilities subindustry, Manipal Health Enterprises's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Manipal Health Enterprises 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Manipal Health Enterprises's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Manipal Health Enterprises's 5-Year Yield-on-Cost % falls into.


BOM:544847
13GF Score
Manipal Health Enterprises Ltd BOM:544847
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Manipal Health Enterprises 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Manipal Health Enterprises is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Manipal Health Enterprises (BOM:544847) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 31, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Manipal Health Enterprises and its competitors. According to the industry distribution chart, Manipal Health Enterprises ranks #999999 out of 280 companies in the Healthcare Providers & Services industry.
Is Manipal Health Enterprises' 5-Year Yield-on-Cost % too high?
Manipal Health Enterprises' current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Manipal Health Enterprises ranks #999999 out of 280 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Manipal Health Enterprises has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Manipal Health Enterprises' 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Manipal Health Enterprises ranks #999999 out of 280 companies for 5-Year Yield-on-Cost %. This places Manipal Health Enterprises in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.95, based on 280 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Manipal Health Enterprises and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Manipal Health Enterprises's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Manipal Health Enterprises stock overvalued right now?
Manipal Health Enterprises (BOM:544847) has a current 5-Year Yield-on-Cost % of 0.00. The current 5-Year Yield-on-Cost % is 0.00. Manipal Health Enterprises' overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Manipal Health Enterprises (BOM:544847), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Manipal Health Enterprises Business Description

Other Exchanges MANIPALHOS:India
Address HAL Airport Road, Rustom Bagh road, The Annexe, no. 98/2, Bengaluru, KA, IND, 560 017
Manipal Health Enterprises Ltd is engaged in the business of running/managing hospitals and providing healthcare services. The company operates through various Hospitals/clinics providing Healthcare services and diagnostic centres in India. It offers clinical services across several specialties, with a focus on tertiary and quaternary care, particularly in cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences. It has a single business segment, namely engaged in the business of healthcare services. The company generates revenue by providing inpatient care at its hospitals.
13GF Score

Get the complete analysis for BOM:544847

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹771.85
Price